Sök i LIBRIS databas

  Utökad sökning


Sökning: onr:"swepub:oai:DiVA.org:lnu-34193" > C-reactive protein ...

C-reactive protein levels in patients at cardiovascular risk : EURIKA study

Halcox, Julian P. J. (författare)
Cardiff University, Wales ; Swansea University College of Medicine, UK
Roy, Carine (författare)
Assistance Publique - Hôpitaux de Paris, France
Tubach, Florence (författare)
Assistance Publique - Hôpitaux de Paris, France ; Paris Diderot University, France
visa fler...
Banegas, Jose R. (författare)
Universidad Autónoma de Madrid, Spain ; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain
Dallongeville, Jean (författare)
Institut Pasteur de Lille, France
De Backer, Guy (författare)
University of Ghent, Belgium
Guallar, Eliseo (författare)
Johns Hopkins Bloomberg School of Public Health, USA ; National Center for Cardiovascular Research, Spain
Sazova, Oguen (författare)
AstraZeneca Global Medical Affairs, -
Medina, Jesus (författare)
AstraZeneca Farmaceutica Holding Spain, Spain
Perk, Joep (författare)
Linnéuniversitetet,Institutionen för hälso- och vårdvetenskap (HV)
Steg, Philippe Gabriel (författare)
Paris Diderot University, France ; Hôpital Bichat-Claude Bernard, France
Rodriguez-Artalejo, Fernando (författare)
Universidad Autónoma de Madrid, Spain
Borghi, Claudio (författare)
University of Bologna, Italy
visa färre...
Ingår i: BMC Cardiovascular Disorders. - 1471-2261 .- 1471-2261. ; 14
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
  • Background: Elevated C-reactive protein (CRP) levels are associated with high cardiovascular risk, and might identify patients who could benefit from more carefully adapted risk factor management. We have assessed the prevalence of elevated CRP levels in patients with one or more traditional cardiovascular risk factors. Methods: Data were analysed from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA, ClinicalTrials. gov Identifier: NCT00882336), which included patients (aged = 50 years) from 12 European countries with at least one traditional cardiovascular risk factor but no history of cardiovascular disease. Analysis was also carried out on the subset of patients without diabetes mellitus who were not receiving statin therapy. Results: In the overall population, CRP levels were positively correlated with body mass index and glycated haemoglobin levels, and were negatively correlated with high- density lipoprotein cholesterol levels. CRP levels were also higher in women, those at higher traditionally estimated cardiovascular risk and those with greater numbers of metabolic syndrome markers. Among patients without diabetes mellitus who were not receiving statin therapy, approximately 30% had CRP levels >= 3 mg/ L, and approximately 50% had CRP levels = 2 mg/ L, including those at intermediate levels of traditionally estimated cardiovascular risk. Conclusions: CRP levels are elevated in a large proportion of patients with at least one cardiovascular risk factor, without diabetes mellitus who are not receiving statin therapy, suggesting a higher level of cardiovascular risk than predicted according to conventional risk estimation systems.


MEDICAL AND HEALTH SCIENCES  -- Health Sciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskaper (hsv//swe)


C-reactive protein
Cardiovascular disease
Risk factors/global assessment
Health and Caring Sciences

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy